穿孔素
颗粒酶B
颗粒酶
白细胞介素15
白细胞介素12
免疫学
自然杀伤细胞
白细胞介素21
流式细胞术
白细胞介素
受体
生物
男科
细胞毒性
细胞因子
T细胞
医学
免疫系统
内科学
细胞毒性T细胞
CD8型
体外
生物化学
作者
Dong‐Pyo Lim,Youn-Young Jang,Seok‐Ho Kim,Sang Seok Koh,Je‐Jung Lee,Ju-Sun Kim,Minh‐Trang Thi Phan,Dong‐Jun Shin,Myung‐Geun Shin,Seung‐Hwan Lee,Meesun Yoon,Sang‐Ki Kim,Jung-Han Yoon,Min‐Ho Park,Duck Cho
出处
期刊:Cytotherapy
[Elsevier BV]
日期:2014-06-18
卷期号:16 (10): 1419-1430
被引量:29
标识
DOI:10.1016/j.jcyt.2014.04.008
摘要
Background aims Interleukin-21 (IL-21) can enhance the effector function of natural killer (NK) cells but also limits their proliferation when continuously combined with IL-2/IL-15. Paradoxically, membrane-bound (mb)-IL-21 has been shown to improve human NK cell proliferation when cultured with IL-2/mb-IL-15. To clarify the role of IL-21, we investigated the effect of the timing of IL-21 addition to NK cell culture. Methods IL-2/IL-15–activated NK cells were additionally treated with IL-21 according to the following schedules; (i) control (without IL-21); (ii) first week (day 0 to day 7); (iii) intermittent (the first 3 days of each week for 7 weeks); (iv) after 1 week (day 8 to day 14); and (v) continuous (day 0 to day 49). The expression of NK receptors, granzyme B, perforin, CD107a, interferon-γ, telomere length and NK cell death were measured by flow cytometry. Results Compared with the control (2004.2-fold; n = 10 healthy donors) and intermittent groups (2063.9-fold), a strong proliferative response of the NK cells on day 42 was identified in the “first week” group (3743.8-fold) (P < 0.05). NK cells treated with IL-21 in the “first week” group showed cytotoxicity similar to that in control cells. On day 28, there was a significant increase in cytotoxicity of “first week” NK cells that received IL-21 treatment for an additional 2 days compared with the “first week” NK cells (P < 0.05). Conclusions These data suggest that controlling temporal exposure of IL-21 during NK cell proliferation can be a critical consideration to improve the yields and cytotoxicity of NK cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI